Hemay808
- Generic Name
- Hemay808
A Phase Ⅱ Study of Hemay808 for Atopic Dermatitis Patients
- First Posted Date
- 2020-04-20
- Last Posted Date
- 2024-03-01
- Lead Sponsor
- Tianjin Hemay Pharmaceutical Co., Ltd
- Target Recruit Count
- 148
- Registration Number
- NCT04352595
- Locations
- 🇨🇳
Dermotology hospital, Chinese academy of medical science, Nanjing, Jiangsu, China
🇨🇳Ningbo second hospital, Ningbo, Zhejiang, China
A Phase I Clinical Study of Hemay808
- First Posted Date
- 2019-09-24
- Last Posted Date
- 2020-04-27
- Lead Sponsor
- Tianjin Hemay Pharmaceutical Co., Ltd
- Target Recruit Count
- 42
- Registration Number
- NCT04100642
- Locations
- 🇨🇳
Dermotology hospital, Chinese academy of medical science, Nanjing, Jiangsu, China
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath